Younger bone marrow donors ‘improve outcomes’ in myelodysplastic syndrome
![](https://www.ausdoc.com.au/wp-content/uploads/2022/08/bone-marrow-dreamstime_s_168936887-1.jpg)
Use of younger, unrelated donors for bone marrow transplants in myelodysplastic syndrome is associated with higher disease-free survival and lower relapse rates, a study shows.
Given the limited treatment options and poor prognosis for relapsed disease, the US researchers say allogeneic haematopoietic cell transplantation (allo-HCT) from such donors could be preferable to using older sibling donors.